Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	498.41	455.73	442.63	402.47	322.11	177.1
Short-Term Investments	393.94	364.65	-	-	-	-
Cash & Short-Term Investments	892.35	820.38	442.63	402.47	322.11	177.1
Cash Growth	-0.99%	85.34%	9.98%	24.95%	81.88%	80.79%
Accounts Receivable	75.88	63.01	52.09	33.58	8.19	2.8
Other Receivables	-	20.09	9.34	23.5	15.03	20.01
Receivables	75.88	83.1	61.44	57.08	23.22	22.81
Inventory	5.66	5.45	4.5	0.69	-	-
Prepaid Expenses	48.96	13.05	10.55	10.11	10.41	8.88
Other Current Assets	-	7.9	9.71	3.62	-	-
Total Current Assets	1,023	929.86	528.82	473.98	355.75	208.8
Property, Plant & Equipment	48.83	47.74	42.74	38.78	42.7	50.31
Long-Term Accounts Receivable	-	-	-	-	-	1.06
Long-Term Deferred Tax Assets	14.33	14.79	10.97	5.12	3.49	3.04
Other Long-Term Assets	16.49	17.12	14.47	8.89	6.68	6.02
Total Assets	1,103	1,010	597	526.76	408.62	269.23
Accounts Payable	22.96	25.1	17.8	14.45	10.15	7.9
Accrued Expenses	134.7	180.77	115.48	73.09	37.11	26.38
Current Portion of Leases	1.88	1.55	1.39	1.88	1.7	2.79
Current Income Taxes Payable	-	-	-	1.12	0.72	0.85
Current Unearned Revenue	0.58	-	-	7.76	33.11	37.02
Other Current Liabilities	10.24	4.76	4.36	2.54	0.05	0.15
Total Current Liabilities	170.35	212.18	139.02	100.84	82.84	75.09
Long-Term Debt	392.59	391.01	48.01	47.81	50.41	50.04
Long-Term Leases	41.4	40.16	35.61	31.76	34.33	34.39
Long-Term Unearned Revenue	5	5.43	5.52	5.24	8.68	33.95
Other Long-Term Liabilities	96.6	-	-	2.22	0.08	0.19
Total Liabilities	705.94	648.79	228.16	187.86	176.33	193.67
Common Stock	0.14	0.14	0.13	0.13	0.12	0.09
Additional Paid-In Capital	1,228	1,190	1,150	1,083	287.38	-
Retained Earnings	-801.22	-795.76	-744.67	-689.39	-651.83	-477.68
Comprehensive Income & Other	-30.01	-33.76	-36.26	-54.67	596.62	553.15
Shareholders' Equity	396.56	360.72	368.84	338.9	232.28	75.56
Total Liabilities & Equity	1,103	1,010	597	526.76	408.62	269.23
Total Debt	435.86	432.72	85.01	81.45	86.44	87.22
Net Cash (Debt)	456.49	387.65	357.62	321.02	235.67	89.88
Net Cash Growth	8.63%	8.40%	11.40%	36.22%	162.22%	366.11%
Net Cash Per Share	9.09	7.75	7.31	7.02	5.55	3.39
Filing Date Shares Outstanding	50.53	50.07	49.82	48.12	43.86	43.79
Total Common Shares Outstanding	50.47	50.06	49.73	48.09	43.86	2.68
Working Capital	852.5	717.68	389.8	373.14	272.91	133.71
Book Value Per Share	7.86	7.20	7.42	7.05	5.30	28.20
Tangible Book Value	396.56	360.72	368.84	338.9	232.28	75.56
Tangible Book Value Per Share	7.86	7.20	7.42	7.05	5.30	28.20
Machinery	-	43.92	41.46	33.98	36.29	35.47
Construction In Progress	-	0.48	0.05	0.43	0.02	0.16
Leasehold Improvements	-	21.02	20.02	19.1	21.18	21.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.